Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan (Q39702326)

14 September 2017

Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan (English)

1 reference

14 September 2017

arterial hypertension

0 references

pharmacotherapy

0 references

author name string

Cheng SF

1

1 reference

14 September 2017

Hsu HH

2

1 reference

14 September 2017

Lee HS

3

1 reference

14 September 2017

Lin CS

4

1 reference

14 September 2017

Chou YC

5

1 reference

14 September 2017

Tien JH

6

1 reference

14 September 2017

1 December 2004

1 reference

Journal of Clinical Pharmacy and Therapeutics

14 September 2017

1 reference

14 September 2017

29

1 reference

14 September 2017

6

1 reference

14 September 2017

547-558

1 reference

Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain

14 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Combination therapy with diuretics: an evolution of understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00599.X

10.1111/J.1365-2710.2004.00599.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference